Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Seitato Fujishima"'
Autor:
Yutaka Umemura, Hiroshi Ogura, Kiyotsugu Takuma, Seitato Fujishima, Toshikazu Abe, Shigeki Kushimoto, Toru Hifumi, Akiyoshi Hagiwara, Atsushi Shiraishi, Yasuhiro Otomo, Daizoh Saitoh, Toshihiko Mayumi, Kazuma Yamakawa, Yasukazu Shiino, Taka-aki Nakada, Takehiko Tarui, Kohji Okamoto, Joji Kotani, Yuichiro Sakamoto, Junichi Sasaki, Shin-ichiro Shiraishi, Ryosuke Tsuruta, Tomohiko Masuno, Naoshi Takeyama, Norio Yamashita, Hiroto Ikeda, Masashi Ueyama, Satoshi Gando
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss , Pp 343-351 (2021)
Background: There is no one-size-fits-all empiric antimicrobial therapy for sepsis because the pathogens vary according to the site of infection and have changed over time. Therefore, updating knowledge on the spectrum of pathogens is necessary for t
Externí odkaz:
https://doaj.org/article/03b993d94e0047b8be8ad18f0b2cf4ca
Autor:
Yutaka Umemura, Toshikazu Abe, Hiroshi Ogura, Seitato Fujishima, Shigeki Kushimoto, Atsushi Shiraishi, Daizoh Saitoh, Toshihiko Mayumi, Yasuhiro Otomo, Toru Hifumi, Akiyoshi Hagiwara, Kiyotsugu Takuma, Kazuma Yamakawa, Yasukazu Shiino, Taka-aki Nakada, Takehiko Tarui, Kohji Okamoto, Joji Kotani, Yuichiro Sakamoto, Junichi Sasaki, Shin-ichiro Shiraishi, Ryosuke Tsuruta, Tomohiko Masuno, Naoshi Takeyama, Norio Yamashita, Hiroto Ikeda, Masashi Ueyama, Satoshi Gando
Publikováno v:
PLoS ONE, Vol 17, Iss 2 (2022)
Background The updated Surviving Sepsis Campaign guidelines recommend a 1-hour window for completion of a sepsis care bundle; however, the effectiveness of the hour-1 bundle has not been fully evaluated. The present study aimed to evaluate the impact
Externí odkaz:
https://doaj.org/article/150ed99d6f5a4bd5b39b330476d0d517
Autor:
Naoshi Takeyama, Kiyotsugu Takuma, Shin Ichiro Shiraishi, Yutaka Umemura, Toshihiko Mayumi, Daizoh Saitoh, Seitato Fujishima, Masashi Ueyama, Takehiko Tarui, Akiyoshi Hagiwara, Kohji Okamoto, Yuichiro Sakamoto, Norio Yamashita, Toru Hifumi, Taka-aki Nakada, Hiroshi Ogura, Joji Kotani, Kazuma Yamakawa, Tomohiko Masuno, Shigeki Kushimoto, Yasuhiro Otomo, Hiroto Ikeda, Ryosuke Tsuruta, Toshikazu Abe, Yasukazu Shiino, Atsushi Shiraishi, Satoshi Gando, Junichi Sasaki
Publikováno v:
International Journal of Infectious Diseases, Vol 103, Iss, Pp 343-351 (2021)
Background There is no one-size-fits-all empiric antimicrobial therapy for sepsis because the pathogens vary according to the site of infection and have changed over time. Therefore, updating knowledge on the spectrum of pathogens is necessary for th
Autor:
Toshikazu Abe, Ryosuke Tsuruta, Toru Hifumi, Norio Yamashita, Ayumi Shintani, Akiyoshi Hagiwara, Hiroshi Ogura, Taka-aki Nakada, Takehiko Tarui, Daizoh Saitoh, Atsushi Shiraishi, Kazuma Yamakawa, Toshihiko Mayumi, Tomohiko Masuno, Joji Kotani, Junichi Sasaki, Kiyotsugu Takuma, Satoshi Fujimi, Yasuhiro Otomo, Hiroto Ikeda, Seitato Fujishima, Yuichiro Sakamoto, Kohji Okamoto, Yasukazu Shiino, Daijiro Kabata, Naoshi Takeyama, Satoshi Gando, Yutaka Umemura, Masashi Ueyama, Shin-Ichiro Shiraishi, Shigeki Kushimoto
Publikováno v:
Thrombosis and Haemostasis. 119:1740-1751
Background Anticoagulant therapy has seldom been achieved in randomized trials targeting nonspecific overall sepsis patients. Although the key components to identify the appropriate target in sepsis may be disseminated intravascular coagulation (DIC)
Autor:
Kazuma Yamakawa, Tomohiko Masuno, Satoshi Gando, Shin-Ichiro Shiraishi, Hiroto Ikeda, Norio Yamashita, Takehiko Tarui, Atsushi Shiraishi, Shigeki Kushimoto, Ryosuke Tsuruta, Yasuhiro Otomo, Yutaka Umemura, Junichi Sasaki, Toru Hifumi, Kiyotsugu Takuma, Akiyoshi Hagiwara, Toshikazu Abe, Seitato Fujishima, Masashi Ueyama, Kohji Okamoto, Daizoh Saitoh, Toshihiko Mayumi, Hiroshi Ogura, Yuichiro Sakamoto, Naoshi Takeyama, Yasukazu Shiino, Joji Kotani, Taka-aki Nakada
Publikováno v:
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 25(12)
Background Sepsis-3 proposed the quick Sequential Organ Failure Assessment (qSOFA) to identify sepsis patients likely to have poor outcome. The clinical utility of qSOFA still remains controversial because its predictive accuracy for mortality is qui